Sandra Sanabria Bohórquez

Medicine · Health Sciences

31h-index4.1kcitations119works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(38), Alzheimer's disease research and treatments(27), Neuroscience and Neuropharmacology Research(23), Dementia and Cognitive Impairment Research(20), Cancer Immunotherapy and Biomarkers(13)

Publications119 total

Heterogeneity of CD8 T-Cell Changes in Advanced Melanomas After Initiation of Immunotherapy
Journal of Nuclear Medicine·2025· 1 citedOpen Access
In Vivo Head-to-Head Comparison of [<sup>18</sup>F]GTP1 with [<sup>18</sup>F]MK-6240 and [<sup>18</sup>F]PI-2620 in Alzheimer Disease
Journal of Nuclear Medicine·2025· 2 citedOpen Access
Cross-sectional and prognostic associations of baseline [ <sup>18</sup> F]GTP1 tau PET signal and white matter lesion volumes for cognitive and functional decline in prodromal-to-mild Alzheimer's disease
Journal of Alzheimer s Disease·2025
CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti‐tau antibody semorinemab
Alzheimer s & Dementia·2024· 11 citedOpen Access
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
Alzheimer s & Dementia·2024· 38 citedOpen Access
Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer’s disease pathophysiology
2024· 1 citedOpen Access
Evaluation of partial volume correction and analysis of longitudinal [18F]GTP1 tau PET imaging in Alzheimer's disease using linear mixed-effects models
Frontiers in Neuroimaging·2024· 1 citedOpen Access
Harmonization of tau‐PET in Alzheimer’s disease: comparison of methods to derive CenTauR units for [18F]RO948, [18F]Flortaucipir, and [18F]MK‐6240
Alzheimer s & Dementia·2023· 2 citedOpen Access
Harmonization of tau‐PET in Alzheimer’s disease: comparison of methods to derive CenTauR units for [<sup>18</sup>F]RO948, [<sup>18</sup>F]Flortaucipir, and [<sup>18</sup>F]MK‐6240
Alzheimer s & Dementia·2023· 1 citedOpen Access
18F GTP1 Tau PET image‐derived features improve the prediction of CDR‐SB progression in a multi‐modal model in prodromal to moderate AD
Alzheimer s & Dementia·2023Open Access
GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP1
Nuclear Medicine and Biology·2023· 1 cited
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
Neurology·2023· 97 citedOpen Access
CenTauR: Toward a universal scale and masks for standardizing tau imaging studies
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·2023· 56 citedOpen Access
CenTauR<sub>z</sub>: A standardized quantification of tau PET scans
Alzheimer s & Dementia·2023· 2 citedOpen Access
Supplementary Tables 1 through 4 and Supplementary Figures 1 through 7 from Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
2023Open Access
Supplementary Figures S1 - S4, Tables S1 - S8 from A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors
2023Open Access
Data from A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors
2023Open Access
Data from Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
2023Open Access
Supplementary Tables 1 through 4 and Supplementary Figures 1 through 7 from Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
2023Open Access
Supplementary Figures S1 - S4, Tables S1 - S8 from A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors
2023Open Access
page 1 of 6Next →

Frequent Co-authors

H. Donald Burns(13), Guy Bormans(13), Inge De Lepeleire(13), Richard Hargreaves(13), Koen Van Laere(12), Terence G. Hamill(10), Jacquelynn J. Cook(10), Jan de Hoon(8), Eric D. Hostetler(8), Waisi Eng(7), Christine Ryan(6), Kerry Riffel(6), Stacey O’Malley(6), Cyrille Sur(6), Anne Van Hecken(5), Edmond Teng(5), Michael E. Ward(5), Geoffrey A. Kerchner(5), Claude Veraart(5), Aniket Joshi(5)